These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28631752)

  • 21. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management strategies in patients with statin-associated muscle symptoms: What is the best strategy?
    Joy TR; Brennan ET
    J Clin Lipidol; 2016; 10(5):1067-72. PubMed ID: 27678422
    [No Abstract]   [Full Text] [Related]  

  • 23. [Statin myopathy--rarity or reality?].
    Pella D
    Vnitr Lek; 2010 Sep; 56(9 Suppl):972-6. PubMed ID: 21137170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing the underestimated risk of statin-associated myopathy.
    Rallidis LS; Fountoulaki K; Anastasiou-Nana M
    Int J Cardiol; 2012 Sep; 159(3):169-76. PubMed ID: 21813193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MY APPROACH to the Patient With Memory Loss Who Needs a Statin.
    Watson KE; Sallam T
    Trends Cardiovasc Med; 2017 Feb; 27(2):158-159. PubMed ID: 28107839
    [No Abstract]   [Full Text] [Related]  

  • 26. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
    Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
    Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin myopathy: a common dilemma not reflected in clinical trials.
    Fernandez G; Spatz ES; Jablecki C; Phillips PS
    Cleve Clin J Med; 2011 Jun; 78(6):393-403. PubMed ID: 21632911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jupiter or Aurora? Micro-inflammation and dyslipidaemia: twin targets for statin therapy in CKD.
    Goldsmith D; Covic AC
    Int Urol Nephrol; 2010 Mar; 42(1):133-6. PubMed ID: 19826907
    [No Abstract]   [Full Text] [Related]  

  • 29. Statin induced myopathy.
    Sathasivam S; Lecky B
    BMJ; 2008 Nov; 337():a2286. PubMed ID: 18988647
    [No Abstract]   [Full Text] [Related]  

  • 30. Statin-induced myopathy.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(3):156-7. PubMed ID: 18568178
    [No Abstract]   [Full Text] [Related]  

  • 31. Statin-associated muscle symptoms: beware of the nocebo effect.
    Pedro-Botet J; Rubiés-Prat J
    Lancet; 2017 Jun; 389(10088):2445-2446. PubMed ID: 28476289
    [No Abstract]   [Full Text] [Related]  

  • 32. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin-induced myopathy in a competitive amateur cyclist.
    Pearce PZ
    Curr Sports Med Rep; 2008; 7(3):149-51. PubMed ID: 18477872
    [No Abstract]   [Full Text] [Related]  

  • 34. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms.
    Orringer CE; Grant JK; Tokgozoglu L
    Curr Atheroscler Rep; 2022 Nov; 24(11):839-847. PubMed ID: 36001213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary Artery Calcium and Shared Decision Making.
    Hecht HS; Shaw LJ; Chandrashekhar Y; Narula J
    JACC Cardiovasc Imaging; 2016 May; 9(5):637-9. PubMed ID: 27151526
    [No Abstract]   [Full Text] [Related]  

  • 37. Statin-induced myopathy: a review and update.
    Abd TT; Jacobson TA
    Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Statins in the management of dyslipidemias].
    Scheen AJ
    Rev Prat; 2011 Oct; 61(8):1120-6. PubMed ID: 22135981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May; 53(5):54-6. PubMed ID: 25977402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Preventive-Pill Paradox: How Shared Decision Making Could Increase Cardiovascular Morbidity and Mortality.
    Diprose W; Verster F
    Circulation; 2016 Nov; 134(21):1599-1600. PubMed ID: 27881503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.